Global Melanoma Cancer Market Research and Forecast 2018-2023

Posted by Orion Market Research on August 3rd, 2018

Melanoma Cancer Market is a skin cancer that develops due to expose of UV rays on the skin. The disease is curable when recognized and treated in the early stages, and hence have a high success rate. Increasing incidence of melanoma across the globe and rising ozone layer depletion due to global warming are the major factors that are driving the market during the forecast period. Additionally, overexposure to radiation during certain treatments or exposure to chemicals during working, increasing awareness about cancer, and rising healthcare expenditure is also motivating the market.

However, certain factors such as high cost associated with treatment, and increasing use of generic medicine are hindering the growth of the market. Medicines such as cisplatin is a generic drug which is off patent and are manufactured by multiple companies for cancer treatment across the globe. Innovation in drug development, and subsequent technological advancements & pipeline products are expected to create significant opportunities for melanoma cancer market.

Related Reports: Healthcare IT Market

On the basis of geographical regions, the market has been segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to dominate in the global melanoma market owing to high prevalence of melanoma in the US and Canada along with a major market share in the region. Well-developed healthcare infrastructure and reimbursement policies are some of the major factors that are contributing towards the growth of the market in the region. Europe is also expected to have major market share during the forecast period. The UK, Germany, and France are the major countries with high prevalence of melanoma. Asia Pacific region is expected to have a considerable market growth during the forecast period owing to key contribution from China, Australia, Japan, and India. Massive pool of patients, rising disposable income and improving healthcare system are the major factors for the growth of the market in the region.

Browse full report at: Global Melanoma Cancer Market Research

Various pharmaceutical companies are active in the melanoma market. Some of the major players include AB Sciences, Incyte, Merck, Novartis, Pierre Fabre, Amgen, AstraZeneca, Bristol-Myers Squibb and Daiichi Sankyo. The companies are focusing on product innovations, expansions, finding new markets or innovate in their core competency in order to expand individual market share. The report includes detailed market overview, strategic recommendations, key company analysis, key findings, analyst insights, market determinants, market segmentation, and company profiling.